✦ LIBER ✦

6118 POSTER Randomized Phase II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) Versus MFOLFOX6 in Patients With Untreated Metastatic Colorectal Cancer (mCRC)

✍ Scribed by Ojima, H.; Yamazaki, K.; Kuwano, H.; Otsuji, T.; Kato, T.; Shimada, K.; Denda, T.; Esaki, T.; Hyodo, I.; Boku, N.

Book ID: 122559266
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)71763-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEAK: A Randomized, Multicenter Phase II

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

✍ Schwartzberg, L. S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J.-L.; Hecht, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 520 KB

465 POSTER Phase I/II study of oxaliplat

465 POSTER Phase I/II study of oxaliplatin (L-OHP) in combination with S-1 (SOX) as first-line therapy for metastatic colorectal cancer (MCRC)

✍ Y. Yamada; A. Ohtsu; M. Tahara; T. Doi; K. Kato; T. Hamaguchi; Y. Shimada; K. Sh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 72 KB

3061 POSTER Phase I/II study of novel or

3061 POSTER Phase I/II study of novel oral fluoropyrimidine S-1 in combination with oxaliplatin (SOX) as first-line chemotherapy for metastatic colorectal cancer (mCRC)

✍ M. Tahara; Y. Yamada; A. Ohtsu; K. Shirao; Y. Shimada; Y. Sasaki; W. Yamamoto; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A phase II open-label randomized multice

A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer

✍ Lee, Jeeyun; Shin, Sang Joon; Chung, Ik Joo; Kim, Tae Won; Chun, Hoo-Geun; Shin, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 313 KB

A randomised phase II study of oxaliplat

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

✍ A. Zori Comba; C. Blajman; E. Richardet; S. Bella; M. Vilanova; F. Cóppola; M. V 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 134 KB

272 A multicenter prospective phase II s

272 A multicenter prospective phase II study of oxaliplatin (OXA), 5-fluorouracil 95FU) and leucovorin (LV) followed, by irininotecan (IRI), 5FU and LV after progression, in patients (pts) with untreated metastatic colorectal carcinoma (MCRC)

✍ C. Almanza; L. De Paz; M. Valladares; M. Jorge; S. Candamio; M. Salgado; C. Cast 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB